PTEN: A molecular target for neurodegeneratIve dIsorders

Translational Neuroscience

Volumn 3, Issue 2, 2012, Pages 132-142

  Ismail, Azza ^a   Ning, Ke ^a   Al Hayani, Abdulmonem ^b   Sharrack, Basil ^c   Azzouz, Mimoun ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b King Abdulaziz University   (Saudi Arabia)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

AKT; Alzheimer's disease; Amyotrophic lateral sclerosis; Apoptosis; Axon; Development; Neuron; Parkinson's disease; PTEN; Regeneration

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BIOLOGICAL ACTIVITY; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; GENE DELETION; GENE SILENCING; HUMAN; MOTOR NEURON DISEASE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE FIBER DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW;

EID: 84864853837     PISSN: 20813856     EISSN: 20816936     Source Type: Journal    
DOI: 10.2478/s13380-012-0018-9     Document Type: Review

References (117)

1. Datta S. R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery, Cell, 1997, 91, 231-241
2. Steck P. A., Pershouse M. A., Jasser S. A., Yung W.K., Lin H., Ligon A. H., et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, Nat. Genet., 1997, 15, 356-362
3. Li D. M., Sun H., TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta, Cancer Res., 1997, 57, 2124-2129
4. Liaw D., Marsh D. J., Li J., Dahia P. L., Wang S. I., Zheng Z., et al., Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome, Nat. Genet., 1997, 16, 64-67
5. Nelen M. R., van Staveren W. C., Peeters E. A., Hassel M. B., Gorlin R. J., Hamm H., et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease, Hum. Mol. Genet., 1997, 6, 1383-1387
6. Marsh D. J., Dahia P. L., Zheng Z., Liaw D., Parsons R., Gorlin R. J., et al., Germline mutations in PTEN are present in Bannayan-Zonana syndrome, Nat. Genet., 1997, 16, 333-334
7. Lee J. O., Yang H., Georgescu M. M., Di Cristofano A., Maehama T., Shi Y., et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association, Cell, 1999, 99, 323-334
8. Wu X., Hepner K., Castelino-Prabhu S., Do D., Kaye M. B., Yuan X. J., et al. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2, Proc. Natl. Acad. Sci. USA, 2000, 97, 4233-4238
9. Georgescu M. M., Kirsch K. H., Akagi T., Shishido T., Hanafusa H., The tumor-suppressor activity of PTEN is regulated by its carboxylterminal region, Proc. Natl. Acad. Sci. USA, 1999, 96, 10182-10187
10. Vazquez F., Ramaswamy S., Nakamura N., Sellers W. R., Phosphorylation of the PTEN tail regulates protein stability and function, Mol. Cell. Biol., 2000, 20, 5010-5018
11. Maehama T., Dixon J. E., The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate, J. Biol. Chem., 1998, 273, 13375-13378
12. Cantley L. C., The phosphoinositide 3-kinase pathway, Science, 2002, 296, 1655-1657
13. Kapeller R., Cantley L. C., Phosphatidylinositol 3-kinase, Bioessays, 1994, 16, 565-576
14. Scheid M. P., Woodgett J. R., Unravelling the activation mechanisms of protein kinase B/Akt, FEBS Lett., 2003, 546, 108-112
15. Datta S. R., Brunet A., Greenberg M. E., Cellular survival: a play in three Akts, Genes Dev., 1999, 13, 2905-2927
16. Kandel E. S., Hay N., The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB, Exp. Cell Res., 1999, 253, 210-229
17. van Weeren P. C., de Bruyn K. M., de Vries-Smits A. M., van Lint J., Burgering B. M., Essential role for protein kinase B (PKB) in insulininduced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB, J. Biol. Chem., 1998, 273, 13150-13156
18. Kops G. J., Burgering B. M., Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling, J. Mol. Med. 1999, 77, 656-665
19. Cardone M. H., Roy N., Stennicke H. R., Salvesen G. S., Franke T. F., Stanbridge E., et al. Regulation of cell death protease caspase-9 by phosphorylation, Science, 1998, 282, 1318-1321
20. Kane L. P., Shapiro V. S., Stokoe D., Weiss A., Induction of NF-kappaB by the Akt/PKB kinase, Curr. Biol., 1999, 9, 601-604
21. Manning B. D., Cantley L. C., United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/ Akt pathway to mammalian target of rapamycin (mTOR) signalling, Biochem. Soc. Trans., 2003, 31, 573-578
22. Laplante M., Sabatini D. M., mTOR signaling at a glance, J. Cell Sci., 2009, 122, 3589-3594
23. Wong E., Cuervo A. M., Autophagy gone awry in neurodegenerative diseases, Nat. Neurosci., 2010, 13, 805-811
24. Caccamo A., Majumder S., Deng J. J., Bai Y., Thornton F. B., Oddo S., Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability, J. Biol. Chem., 2009, 284, 27416-27424
25. Malagelada C., Jin Z. H., Jackson-Lewis V., Przedborski S., Greene L. A., Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease, J. Neurosci., 2010, 30, 1166-1175
26. Bove J., Martinez-Vicente M., Vila M., Fighting neurodegeneration with rapamycin: mechanistic insights, Nat. Rev. Neurosci., 2011, 12, 437-452
27. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., Yamada K. M., Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN, Science, 1998, 280, 1614-1617
28. Podsypanina K., Ellenson L. H., Nemes A., Gu J., Tamura M., Yamada K. M., et al., Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems, Proc. Natl. Acad. Sci. USA, 1999, 96, 1563-1568
29. Ning K., Miller L. C., Laidlaw H. A., Burgess L. A., Perera N. M., Downes C. P., et al., A novel leptin signalling pathway via PTEN inhibition in hypothalamic cell lines and pancreatic beta-cells, EMBO J., 2006, 25, 2377-2387
30. Ning K., Miller L. C., Laidlaw H. A., Watterson K. R., Gallagher J., Sutherland C., et al., Leptin-dependent phosphorylation of PTEN mediates actin restructuring and activation of ATP-sensitive K+ channels, J. Biol. Chem., 2009, 284, 9331-9340
31. Weng L. P., Smith W. M., Brown J. L., Eng C., PTEN inhibits insulinstimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model, Hum. Mol. Genet., 2001, 10, 605-616
32. Waite K. A., Eng C., Protean PTEN: form and function, Am. J. Hum. Genet., 2002, 70, 829-844
33. Lachyankar M. B., Sultana N., Schonhoff C. M., Mitra P., Poluha W., Lambert S., et al., A role for nuclear PTEN in neuronal differentiation, J. Neurosci., 2000, 20, 1404-1413
34. Sano T., Lin H., Chen X., Langford L. A., Koul D., Bondy M. L., et al., Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis, Cancer Res., 1999, 59, 1820-1824
35. Goberdhan D. C., Paricio N., Goodman E. C., Mlodzik M., Wilson C., Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway, Genes Dev., 1999, 13, 3244-3258
36. Huang H., Potter C. J., Tao W., Li D. M., Brogiolo W., Hafen E., et al., PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development, Development, 1999, 126, 5365-5372
37. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P. P., Pten is essential for embryonic development and tumour suppression, Nat. Genet., 1998,19, 348-355
38. Suzuki A., de la Pompa J. L., Stambolic V., Elia A. J., Sasaki T., del Barco Barrantes I., et al., High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice, Curr. Biol., 1998, 8, 1169-1178
39. Vasconsuelo A., Pronsato L., Ronda A. C., Boland R., Milanesi L., Role of 17β-estradiol and testosterone in apoptosis, Steroids, 2011, 76, 1223-1231
40. Groszer M., Erickson R., Scripture-Adams D. D., Lesche R., Trumpp A., Zack J. A., et al., Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo, Science, 2001, 294, 2186-2189
41. Li L., Liu F., Salmonsen R. A., Turner T. K., Litofsky N. S., Di Cristofano A., et al., PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation, Mol. Cell. Neurosci., 2002, 20, 21-29
42. Marino S., Krimpenfort P., Leung C., van der Korput H. A. G. M., Trapman J., Camenisch I., et al., PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum, Development, 2002, 129, 3513-3522
43. Backman S. A., Stambolic V., Suzuki A., Haight J., Elia A., Pretorius J., et al., Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease, Nat. Genet., 2001, 29, 396-403
44. Kwon C. H., Zhu X., Zhang J., Knoop L. L., Tharp R., Smeyne R. J., et al., Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease, Nat. Genet., 2001, 29, 404-411
45. Kyrylenko S., Roschier M., Korhonen P., Salminen A., Regulation of PTEN expression in neuronal apoptosis, Mol. Brain Res., 1999, 73, 198-202
46. Smith J. A., Zhang R., Varma A. K., Das A., Ray S. K., Banik N. L., Estrogen partially down-regulates PTEN to prevent apoptosis in VSC4.1 motoneurons following exposure to IFN-gamma, Brain Res., 2009, 1301, 163-170
47. Xu J., Yeon J. E., Chang H., Tison G., Chen G. J., Wands J., et al., Ethanol impairs insulin-stimulated neuronal survival in the developing brain: role of PTEN phosphatase, J. Biol. Chem., 2003, 278, 26929-26937
48. Gary D. S., Mattson M. P., PTEN regulates Akt kinase activity in hippocampal neurons and increases their sensitivity to glutamate and apoptosis, Neuromolecular Med., 2002, 2, 261-269
49. Delgado-Esteban M., Martin-Zanca D., Andres-Martin L., Almeida A., Bolanos J. P., Inhibition of PTEN by peroxynitrite activates the phosphoinositide-3-kinase/Akt neuroprotective signaling pathway, J. Neurochem., 2007, 102, 194-205
50. Zhao H., Shimohata T., Wang J. Q., Sun G., Schaal D. W., Sapolsky R. M., et al., Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats, J. Neurosci., 2005, 25, 9794-9806
51. Zhang Q.-G., Wu D.-N., Han D., Zhang G.-Y., Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury, FEBS Lett., 2007, 581, 495-505
52. Ning K., Pei L., Liao M., Liu B., Zhang Y., Jiang W., et al., Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN, J. Neurosci. 2004, 24, 4052-4060
53. Liu B., Li L., Zhang Q., Chang N., Wang D., Shan Y., et al., Preservation of GABAA receptor function by PTEN inhibition protects against neuronal death in ischemic stroke, Stroke, 2010, 41, 1018-1026
54. Cheung N. S., Choy M. S., Halliwell B., Teo T. S., Bay B. H., Lee A. Y. W., et al., Lactacystin-induced apoptosis of cultured mouse cortical neurons is associated with accumulation of PTEN in the detergent-resistant membrane fraction, Cell. Mol. Life Sci., 2004, 61, 1926-1934
55. Choy M. S., Bay B. H., Cheng H.-C., Cheung N. S., PTEN is recruited to specific microdomains of the plasma membrane during lactacystininduced neuronal apoptosis, Neurosci. Lett., 2006, 405, 120-125
56. Zhang X., Li F., Bulloj A., Zhang Y.-W., Tong G., Zhang Z., et al., Tumorsuppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules, FASEB J., 2006, 20, 1272-1274
57. Zhu Y., Hoell P., Ahlemeyer B., Sure U., Bertalanffy H., Krieglstein J., Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease, Neurochem. Int., 2007, 50, 507-516
58. Park K. K., Liu K., Hu Y., Smith P. D., Wang C., Cai B., et al., Promoting axon regeneration in the adult CNS by modulation of the PTEN/ mTOR pathway, Science, 2008, 322, 963-966
59. Liu K., Lu Y., Lee J. K., Samara R., Willenberg R., Sears-Kraxberger I., et al., PTEN deletion enhances the regenerative ability of adult corticospinal neurons, Nat. Neurosci., 2010, 13, 1075-1081
60. Jiang H., Guo W., Liang X., Rao Y., Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators, Cell, 2005, 120, 123-135
61. Arevalo M.-A., Rodriguez-Tebar A., Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3beta and stimulate axonal growth, Mol. Biol. Cell, 2006, 17, 3369-3377
62. Sun F., Park K. K., Belin S., Wang D., Lu T., Chen G., et al., Sustained axon regeneration induced by co-deletion of PTEN and SOCS3, Nature, 2011, 480, 372-375
63. Leibinger M., Andreadaki A., Fischer D., Role of mTOR in neuroprotection and axon regeneration after inflammatory stimulation, Neurobiol. Dis., 2012, 46, 314-324
64. Ning K., Drepper C., Valori C. F., Ahsan M., Wyles M., Higginbottom A., et al., PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons, Hum. Mol. Genet., 2010, 19, 3159-3168
65. Perandones C., Costanzo R. V., Kowaljow V., Pivetta O. H., Carminatti H., Radrizzani M., Correlation between synaptogenesis and the PTEN phosphatase expression in dendrites during postnatal brain development, Mol. Brain Res., 2004, 128, 8-19
66. Fraser M. M., Bayazitov I. T., Zakharenko S. S., Baker S. J., Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities, Neuroscience, 2008, 151, 476-488
67. Xiong Q., Oviedo H. V., Trotman L. C., Zador A. M., PTEN regulation of local and long-range connections in mouse auditory cortex, J. Neurosci., 2012, 32, 1643-1652
68. Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M., Binder L. I., Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. USA, 1986, 83, 4913-4917
69. Stein T. D., Johnson J. A., Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways, J. Neuroscience, 2002, 22, 7380-7388
70. Wei W., Wang X., Kusiak J. W., Signaling events in amyloid betapeptide-induced neuronal death and insulin-like growth factor I protection, J. Biol. Chem., 2002, 277, 17649-17656
71. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P., Anderton B. H., Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase, Neurosci. Lett., 1992, 147, 58-62
72. Mandelkow E. M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J. R., et al., Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau, FEBS Lett., 1992, 314, 315-321
73. Lovestone S., Reynolds C. H., Latimer D., Davis D. R., Anderton B. H., Gallo J. M., et al., Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells, Curr. Biol., 1994, 4, 1077-1086
74. Myers A., Holmans P., Marshall H., Kwon J., Meyer D., Ramic D., et al., Susceptibility locus for Alzheimer's disease on chromosome 10, Science, 2000, 290, 2304-2305
75. Hamilton G., Samedi F., Knight J., Archer N., Foy C., Walter S., et al., Polymorphisms in the phosphate and tensin homolog gene are not associated with late-onset Alzheimer's disease, Neurosci. Lett., 2006, 401, 77-80
76. Griffin R. J., Moloney A., Kelliher M., Johnston J. A., Ravid R., Dockery P., et al., Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology, J. Neurochem., 2005, 93, 105-117
77. Kwak Y. D., Ma T., Diao S, Zhang X., Chen Y., Hsu J., et al., NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration, Mol. Neurodegener., 2010, 10, 49
78. Sonoda Y., Mukai H., Matsuo K., Takahashi M., Ono Y., Maeda K., et al., Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles, Neurosci. Lett., 2010, 471, 20-24
79. Kerr F., Rickle A., Nayeem N., Brandner S., Cowburn R. F., Lovestone S., PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3, FEBS Lett., 2006, 580, 3121-3128
80. Rickle A., Bogdanovic N., Volkmann I., Zhou X., Pei J.-J., Winblad B., et al., PTEN levels in Alzheimer's disease medial temporal cortex, Neurochem. Int., 2006, 48, 114-123
81. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 1993, 362, 59-62 Erratum appears in Nature, 1993, 364, 362
82. Sathasivam S., Shaw P. J., Apoptosis in amyotrophic lateral sclerosis-what is the evidence?, Lancet Neurol., 2005, 4, 500-509
83. Kiryu S., Morita N., Ohno K., Maeno H., Kiyama H., Regulation of mRNA expression involved in Ras and PKA signal pathways during rat hypoglossal nerve regeneration, Mol. Brain Res., 1995, 29, 147-156
84. Ito Y., Sakagami H., Kondo H., Enhanced gene expression for phosphatidylinositol 3-kinase in the hypoglossal motoneurons following axonal crush, Mol. Brain Res., 1996, 37, 329-332
85. Namikawa K., Honma M., Abe K., Takeda M., Mansur K., Obata T., et al., Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration, J. Neurosci., 2000, 20, 2875-2886
86. Newbern J., Taylor A., Robinson M., Li L., Milligan C. E., Decreases in phosphoinositide-3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling activate components of spinal motoneuron death, J. Neurochem., 2005, 94, 1652-1665
87. Lunn J. S., Sakowski S. A., Kim B., Rosenberg A. A., Feldman E. L., Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration, Dev. Neurobiol., 2009, 69, 871-884
88. Tolosa L., Mir M., Olmos G., Llado J., Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition, Neuroscience, 2009, 158, 1348-1355
89. Tolosa L., Mir M., Asensio V. J., Olmos G., Llado J., Vascular endothelial growth factor protects spinal cord motoneurons against glutamateinduced excitotoxicity via phosphatidylinositol 3-kinase, J. Neurochem., 2008, 105, 1080-1090
90. Kaspar B. K., Llado J., Sherkat N., Rothstein J. D., Gage F. H., Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model, Science, 2003, 301, 839-842
91. Vincent A. M., Mobley B. C., Hiller A., Feldman E. L., IGF-I prevents glutamate-induced motor neuron programmed cell death, Neurobiol. Dis., 2004, 16, 407-416
92. Manabe Y., Nagano I., Gazi M. S. A., Murakami T., Shiote M., Shoji M., et al., Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis, Apoptosis, 2002, 7, 329-334
93. Lim E., Lee S., Li E., Kim Y., Park S., Ghrelin protects spinal cord motoneurons against chronic glutamate-induced excitotoxicity via ERK1/2 and phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3beta pathways, Exp. Neurol., 2011, 230, 114-122
94. Kirby J., Ning K., Ferraiuolo L., Heath P. R., Ismail A., Kuo S.-W., et al., Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis, Brain, 2011, 134, 506-517
95. Wagey R., Pelech S. L., Duronio V., Krieger C., Phosphatidylinositol 3-kinase: increased activity and protein level in amyotrophic lateral sclerosis, J. Neurochem., 1998, 71, 716-722
96. Dewil M., Lambrechts D., Sciot R., Shaw P. J., Ince P. G., Robberecht W., et al., Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis, Neuropathol. Appl. Neurobiol., 2007, 33, 499-509
97. Warita H., Manabe Y., Murakami T., Shiro Y., Nagano I., Abe K., Early decrease of survival signal-related proteins in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene, Apoptosis, 2001, 6, 345-352
98. Nagano I., Murakami T., Manabe Y., Abe K., Early decrease of survival factors and DNA repair enzyme in spinal motor neurons of presymptomatic transgenic mice that express a mutant SOD1 gene, Life Sci., 2002, 72, 541-548
99. Schapira A. H., Jenner P., Etiology and pathogenesis of Parkinson's disease, Mov. Disord., 2011, 26, 1049-1055
100. Chesselet M.-F., Richter F., Modelling of Parkinson's disease in mice, Lancet Neurol., 2011, 10, 1108-1118
101. Valente E. M., Abou-Sleiman P. M., Caputo V., Muqit M. M. K., Harvey K., Gispert S., et al., Hereditary early-onset Parkinson's disease caused by mutations in PINK1, Science, 2004, 304, 1158-1160
102. Greene L. A., Levy O., Malagelada C., Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment, Cell. Mol. Neurobiol., 31, 969-978
103. Timmons S., Coakley M. F., Moloney A. M., O' Neill C., Akt signal transduction dysfunction in Parkinson's disease, Neurosci. Lett., 2009, 467, 30-35
104. Chen G., Bower K. A., Ma C., Fang S., Thiele C. J., Luo J., Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamineinduced neuronal death, FASEB J., 2004, 18, 1162-1164
105. Ries V., Henchcliffe C., Kareva T., Rzhetskaya M., Bland R., During M. J., et al., Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease, Proc. Natl. Acad. Sci. USA, 2006, 103, 18757-18762
106. Goedert M., Familial Parkinson's disease. The awakening of alphasynuclein, Nature, 1997, 388, 232-233
107. Heintz N., Zoghbi H., alpha-Synuclein-a link between Parkinson and Alzheimer diseases? Nat. Genet., 1997, 16, 325-327
108. Hashimoto M., Bar-On P., Ho G., Takenouchi T., Rockenstein E., Crews L., et al., Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease, J. Biol. Chem., 2004, 279, 23622-23629
109. Shimoke K., Chiba H., Nerve growth factor prevents 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease, J. Neurosci. Res., 2001, 63, 402-409
110. Cookson M. R., Molecules that cause or prevent Parkinson's disease, PLoS Biol., 2004, 2, e401
111. Kim R. H., Peters M., Jang Y., Shi W., Pintilie M., Fletcher G. C., et al., DJ-1, a novel regulator of the tumor suppressor PTEN, Cancer Cell, 2005, 7, 263-273
112. Yang Y., Gehrke S., Haque M. E., Imai Y., Kosek J., Yang L., et al., Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling, Proc. Natl. Acad. Sci. USA, 2005, 102, 13670-13675
113. Diaz-Ruiz O., Zapata A., Shan L., Zhang Y., Tomac A. C., Malik N., et al., Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons, PLoS One, 2009, 4, e7027
114. Domanskyi A., Geissler C., Vinnikov I. A., Alter H., Schober A., Vogt M. A., et al., Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models, FASEB J., 2011, 25, 2898-2910
115. Ji S.-P., Zhang Y., Van Cleemput J., Jiang W., Liao M., Li L., et al., Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse, Nat. Med., 2006, 12, 324-329
116. Marsh D. J., Roth S., Lunetta K. L., Hemminki A., Dahia P. L., Sistonen P., et al., Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome, Cancer Res., 1997, 57, 5017-5021
117. Chang N., El-Hayek Y. H., Gomez E., Wan Q., Phosphatase PTEN in neuronal injury and brain disorders, Trends Neurosci., 2007, 30, 581-586